Hypoxia: The driving force of uterine myometrial stem cells differentiation into leiomyoma cells

Medical Hypotheses

Volumn 77, Issue 6, 2011, Pages 985-986

  Zhou, Shengtao ^a,b   Yi, Tao ^a   Shen, Kai ^b   Zhang, Boya ^b   Huang, Fuqiang ^b   Zhao, Xia ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; HORMONE RELEASE; HUMAN; HYPOXIA; LEIOMYOMA; MICROENVIRONMENT; MYOMETRIUM; SIGNAL TRANSDUCTION; STEM CELL;

ANOXIA; CELL DIFFERENTIATION; FEMALE; HUMANS; LEIOMYOMA; MODELS, BIOLOGICAL; MYOMETRIUM; SIGNAL TRANSDUCTION; UTERINE NEOPLASMS;

EID: 80755135497     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.08.026     Document Type: Article

References (16)

1. Duhan N., Sirohiwal D. Uterine myomas revisited. Eur J Obst Gyn Reprod Biol 2010, 152:119-125.
2. Wallach E.E., Vlahos N.F. Uterine myomas: an overview of development clinical features and management. Obst Gynecol 2004, 104:393-406.
3. Arnulf M., Michael H., Alexander W., et al. Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res 2008, 68:4719-4726.
4. Masanori O., Tetsuo M., Hirotaka M., et al. Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc Natl Acad Sci USA 2007, 104:18700-18705.
5. Ken F., Masatoshi K., Masato K., et al. Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic. Environment and unrelated to proliferative activity. J Clin Endocrinol Metab 2002, 87:1729-1736.
6. Fujii S., Konishi I., Horiuchi A., et al. Mesenchymal cell differentiation: speculation about the histogenesis of uterine leiomyomas. Pathogenesis and medical management of uterine fibroids 1999, 3-15. The Parthenon Publishing Group, New York. I.A. Brosens, B. Lunenfeld, J. Donnez (Eds.).
7. Arnulf M., Michael H., Angelika W., et al. HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas. Oxygen Transport to Tissue XXXI. Adv Exp Med Biol 2010, 399-405.
8. Wang X.T., Kumar D., Seidman J.D. Uterine lipoleiomyomas: a clinicopathologic study of 50 cases. Int J Gynecol Pathol 2006, 25:239-242.
9. Bhattacharya N., Sengupta J. Ossification of leiomyoma. J Ind Med Assoc 1998, 96:99.
10. Chang H.L., Senaratnea T.N., Zhang L.H., et al. Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normalmyometrium. Reprod Sci 2010, 17:158-167.
11. Jakimiuk A.J., Bogusiewicz M., Tarkowski R., et al. Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fert Steril 2004, 82:1244-1249.
12. Stoner M., Saville B., Wormke M., Dean D., Burghardt R., Safe S. Hypoxia induces proteasome-dependent degradation of estrogen receptor a in ZR-75 breast cancer cells. Mol Endocrinol 2002, 16:2231-2242.
13. Brandon D.D., Erickson T.E., Keenan E.J. Estrogen-receptor gene-expression in human uterine leiomyoma. J Clin Endocrinol Metab 1995, 80:1876-1881.
14. Brannvall K., Korhonen L., Lindholm D. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol Cell Neurosci 2002, 21:512-520.
15. Blanpain C., Horsley V., Fuchs E. Epithelial stem cells: turning over new leaves. Cell 2007, 128:445-458.
16. Zhao J.W., Li Z., Hong M., Lin L.Y., Yan W. Differentiation of human mesenchymal stem cells: the potential mechanism for estrogen-induced preferential osteoblast versus adipocyte differentiation. Am J Med Sci 2011, 2.